Altwegg, Romain <br/><br/>
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.  [electronic resource] 

 -  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver  07 2018 
 - 668-674 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1878-3562 
<br/><br/><label>Standard No.: </label>10.1016/j.dld.2018.02.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adolescent<br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Cholangitis, Sclerosing--complications<br/>Colonoscopy<br/>Colorectal Neoplasms<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>France<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab--therapeutic use<br/>Liver Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Retrospective Studies<br/>Tacrolimus--therapeutic use<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult